TETRACOSACTIDE

Information current as at: 1 June 2026

PBAC meeting date: May 2021
Legend: Completed N In progress Not applicable N Yet to commence

Submission Details

Brand name:
  • Synacthen®
Form and strength:
Please search for and view the medicine's Public Summary Document (PSD) for more information
Submission sponsor:
Clinect Pty Ltd
Condition/indication:
(therapeutic use)
  • Hypsarrhythmia and/or infantile spasms
Listing requested:
Please see PSD for more information
Funding program:
Please see PSD for more information
Request authority level:
Please see PSD for more information
PBAC Submission type:
Change to listing (Matters outstanding)
Comment:
At its meeting on 7 May 2021, the PBAC decided to advise the Minister (under section 101(4AAB) of the National Health Act 1953 (“the Act’)) in relation to the proposed revocation of the declaration that tetracosactide is a drug to which Part VII of the Act applies. When the PBAC makes a recommendation under section 101(3) of the National Health Act 1953 (“the Act”) in relation to a drug/medicinal preparation which it considers should be made available as a pharmaceutical benefit under Part VII of the Act, it is also required to consider whether the drug/medicinal preparation should be made available only in certain circumstances (see section 101(3C) of the Act). Where the PBAC considers that the drug/medicinal preparation should be made available only in certain circumstances, it specifies the circumstances in its recommendation under section 101(3). At its meeting on 7 May 2021, the PBAC decided not to recommend to the Minister (under section 101(3)) that the circumstances, under which tetracosactide is made available as a pharmaceutical benefit, be changed.
Other PBAC consideration:

Progress Details

Submission received for:
May 2021 PBAC meeting
Opportunity for consumer comment:
--
PBAC meeting:
Held on 07/05/2021
PBAC outcome published:
Not Applicable (see PBAC Outcomes)
Lodgement of required documentation:
Not applicable
Agreement to listing arrangements:
Not applicable
Government processes:
Not applicable
Medicine listed on the PBS:
Not applicable
Glossary

PBAC Outcome

PBAC Recommendation:
Please see the Outcomes from the relevant meeting for more information
Case ID
a388
Page last updated
31 March 2026
Return to the Medicine Status Listing
v.9.19